SMT: Engineered microbial assays

The management of Small Molecule Therapeutics Inc. is driven by a fundamental motivation: After years of building drug discovery programs for pharmaceutical companies, the time had come to reap the benefits themselves.

"We have been successful in identifying leads and using new technologies to develop successful drug discovery programs," said CEO and CSO Prabhavathi Fernandes, referring to herself and co-founder Rolf Menzel as well as others on her staff who cut their teeth in big pharma's drug discovery departments. "We wanted to build the same success for ourselves."...